|
🐜
|
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
44 auth.
V. Poeschel,
G. Held,
M. Ziepert,
M. Witzens‐Harig,
H. Holte,
L. Thurner,
P. Borchmann,
A. Viardot,
M. Soekler,
U. Keller,
C. Schmidt,
L. Truemper,
R. Mahlberg,
R. Marks,
H. Hoeffkes,
...
B. Metzner,
J. Dierlamm,
N. Frickhofen,
M. Haenel,
A. Neubauer,
M. Kneba,
F. Merli,
A. Tucci,
P. Brown,
M. Federico,
E. Lengfelder,
A. Rocco,
R. Trappe,
A. Rosenwald,
C. Berdel,
Martin Maisenhoelder,
O. Shpilberg,
Josif Amam,
K. Christofyllakis,
F. Hartmann,
N. Murawski,
S. Stilgenbauer,
M. Nickelsen,
G. Wulf,
B. Glass,
N. Schmitz,
B. Altmann,
M. Loeffler,
M. Pfreundschuh
|
7 |
2019 |
7
🐜
|
|
🐬
|
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
M. Niewald,
C. Berdel,
J. Fleckenstein,
N. Licht,
R. Ketter,
C. Rübe
|
5 |
2011 |
5
🐬
|
|
🐜
|
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
19 auth.
M. Pfreundschuh,
N. Murawski,
S. Zeynalova,
M. Ziepert,
M. Loeffler,
M. Hänel,
J. Dierlamm,
U. Keller,
M. Dreyling,
L. Truemper,
...
N. Frickhofen,
A. Hünerlitürkoglu,
N. Schmitz,
V. Pöschel,
T. Rixecker,
C. Berdel,
C. Rübe,
G. Held,
C. Zwick
|
5 |
2017 |
5
🐜
|
|
🐜
|
Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA.
19 auth.
M. Pfreundschuh,
N. Murawski,
M. Ziepert,
B. Altmann,
M. Dreyling,
P. Borchmann,
S. Luminari,
M. Witzens‐Harig,
J. Dierlamm,
M. Haenel,
...
L. Truemper,
B. Metzner,
E. Lengfelder,
U. Keller,
C. Ruebe,
C. Berdel,
N. Schmitz,
G. Held,
V. Poeschel
|
5 |
2018 |
5
🐜
|
|
🐜
|
Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA
25 auth.
V. Poeschel,
G. Held,
M. Ziepert,
B. Altmann,
M. Witzens‐Harig,
H. Holte,
L. Thurner,
A. Viardot,
P. Borchmann,
L. Kanz,
U. Keller,
C. Schmidt,
R. Mahlberg,
B. Metzner,
R. Marks,
...
H. Hoeffkes,
K. Christofyllakis,
Josif Amam,
C. Berdel,
S. Stilgenbauer,
N. Schmitz,
L. Truemper,
N. Murawski,
M. Loeffler,
M. Pfreundschuh
|
4 |
2018 |
4
🐜
|
|
🐜
|
RADIOTHERAPY TO BULKY DISEASE PET‐NEGATIVE AFTER IMMUNOCHEMOTHERAPY CAN BE SPARED IN ELDERLY DLBCL PATIENTS: RESULTS OF a PLANNED INTERIM ANALYSIS OF THE FIRST 187 PATIENTS WITH BULKY DISEASE TREATED IN THE OPTIMAL > 60 STUDY OF THE DSHNHL
21 auth.
M. Pfreundschuh,
K. Christofyllakis,
B. Altmann,
M. Ziepert,
M. Haenel,
A. Viardot,
A. Neubauer,
G. Held,
L. Truemper,
M. Dreyling,
...
L. Kanz,
M. Hallek,
N. Schmitz,
T. Heintges,
C. Kölbel,
A. Buecker,
C. Ruebe,
D. Hellwig,
C. Berdel,
V. Poeschel,
N. Murawski
|
3 |
2017 |
3
🐜
|
|
🐜
|
Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: A subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA).
21 auth.
G. Held,
L. Thurner,
V. Poeschel,
C. Berdel,
G. Ott,
C. Schmidt,
A. Viardot,
P. Borchmann,
O. Shpilberg,
M. Nickelsen,
...
M. Federico,
P. Brown,
N. Murawski,
L. Trümper,
H. Schmidberger,
C. Ruebe,
J. Fleckenstein,
N. Schmitz,
M. Loeffler,
M. Ziepert,
German Lymphoma Alliance
|
3 |
2020 |
3
🐜
|
|
🐜
|
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study
47 auth.
L. Thurner,
M. Ziepert,
C. Berdel,
C. Schmidt,
P. Borchmann,
D. Kaddu-Mulindwa,
A. Viardot,
M. Witzens‐Harig,
J. Dierlamm,
Mathias Haenel,
B. Metzner,
G. Wulf,
Eva Lengfelder,
U. Keller,
N. Frickhofen,
...
M. Nickelsen,
T. Gaska,
F. Griesinger,
R. Mahlberg,
R. Marks,
O. Shpilberg,
H. Lindemann,
M. Soekler,
L. Fischer von Weikersthal,
M. Kiehl,
E. Roemer,
M. Bentz,
B. Krammer-Steiner,
R. Trappe,
P. de Nully Brown,
M. Federico,
F. Merli,
M. Engelhard,
B. Glass,
N. Schmitz,
L. Truemper,
M. Bewarder,
F. Hartmann,
N. Murawski,
S. Stilgenbauer,
A. Rosenwald,
B. Altmann,
H. Schmidberger,
J. Fleckenstein,
M. Loeffler,
V. Poeschel,
G. Held
|
2 |
2023 |
2
🐜
|
